Clinical Trial Update: Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)

View source ↗

Summary

This document reports a completed longitudinal registry (PEARL) evaluating the effectiveness of Paliperidone Palmitate in schizophrenia. The snippet does not in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone palmitate (Paliperidone palmitate)

Snippet

Sponsor: Janssen-Cilag Pty Ltd | Conditions: Schizophrenia | Status: COMPLETED